Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuminori Sakurai

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Biological & Pharmaceutical Bulletin|October 2, 2008
Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35Fuminori Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 2, 2008
[Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35]Fuminori Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 5, 2010
[Development of recombinant adenovirus carrying microRNA-regulated gene expression system]Fuminori Sakurai, Hiroyuki Mizuguchi
Drug Metabolism and Pharmacokinetics|January 2, 2022
Adenovirus vector-based vaccine for infectious diseasesFuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
MicroRNA-regulated transgene expression systems for gene therapy and virotherapyFuminori Sakurai, Kazufumi Katayama, Hiroyuki Mizuguchi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2006
[Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates]Fuminori Sakurai, Kenji Kawabata, Hiroyuki Mizuguchi
Molecular Therapy Oncolytics|February 22, 2019
Systemically Administered Reovirus-Induced Downregulation of Hypoxia Inducible Factor-1α in Subcutaneous TumorsTakuma Hotani, Hiroyuki Mizuguchi, Fuminori Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 1, 2026
[Association between the Risk of Drug-induced Liver Injury and the Reactive Metabolites Acyl Glucuronides]Atsushi Kawase, Hiroaki Shimada, Fuminori Sakurai
Current Gene Therapy|November 1, 2007
Adenovirus vectors composed of subgroup B adenovirusesFuminori Sakurai, Kenji Kawabata, Hiroyuki Mizuguchi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 2, 2013
[Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus]Fuminori Sakurai, Toshiyoshi Fujiwara, Hiroyuki Mizuguchi
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Biological & Pharmaceutical Bulletin|October 2, 2008
Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35Fuminori Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 2, 2008
[Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35]Fuminori Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 5, 2010
[Development of recombinant adenovirus carrying microRNA-regulated gene expression system]Fuminori Sakurai, Hiroyuki Mizuguchi
Drug Metabolism and Pharmacokinetics|January 2, 2022
Adenovirus vector-based vaccine for infectious diseasesFuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
MicroRNA-regulated transgene expression systems for gene therapy and virotherapyFuminori Sakurai, Kazufumi Katayama, Hiroyuki Mizuguchi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2006
[Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates]Fuminori Sakurai, Kenji Kawabata, Hiroyuki Mizuguchi
Molecular Therapy Oncolytics|February 22, 2019
Systemically Administered Reovirus-Induced Downregulation of Hypoxia Inducible Factor-1α in Subcutaneous TumorsTakuma Hotani, Hiroyuki Mizuguchi, Fuminori Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 1, 2026
[Association between the Risk of Drug-induced Liver Injury and the Reactive Metabolites Acyl Glucuronides]Atsushi Kawase, Hiroaki Shimada, Fuminori Sakurai
Current Gene Therapy|November 1, 2007
Adenovirus vectors composed of subgroup B adenovirusesFuminori Sakurai, Kenji Kawabata, Hiroyuki Mizuguchi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 2, 2013
[Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus]Fuminori Sakurai, Toshiyoshi Fujiwara, Hiroyuki Mizuguchi
Pageof 17